EPISODE · Feb 1, 2022 · 10 MIN
Casirivimab and Imdevimab for Early Asymptomatic SARS-CoV-2 Infection, Hypothermia vs Normothermia for Cardiogenic Shock and Extracorporeal Membrane Oxygenation, Familial Idiopathic Dilated Cardiomyopathy, and more
Editor's Summary by Linda Brubaker, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the February 1, 2022, issue.
Embed this episode
Ready to play
Casirivimab and Imdevimab for Early Asymptomatic SARS-CoV-2 Infection, Hypothermia vs Normothermia for Cardiogenic Shock and Extracorporeal Membrane Oxygenation, Familial Idiopathic Dilated Cardiomyopathy, and more
0:00
10:56
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of JAMA Editors' Summary?
This episode is 10 minutes long.
When was this JAMA Editors' Summary episode published?
This episode was published on February 1, 2022.
Can I download this JAMA Editors' Summary episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!